InvestingMarketSmith India Sets ₹480 and ₹1,500 Targets for Apollo Micro Systems and Dr. Reddy’sBy Celia RowanOct 27, 2026, 12:52 AM UTC
InvestingThe Economic Times Reports Dr. Reddy’s Shares Above ₹1,266.90 ResistanceBy Celia RowanOct 26, 2026, 4:49 AM UTC
InvestingHindustan Times Reports India’s Benchmarks Open Lower as Oil EasesBy Celia RowanOct 26, 2026, 4:12 AM UTC
InvestingDr. Reddy’s Laboratories Draws Calls From Sell to Buy After Q2 ResultsBy Celia RowanOct 26, 2026, 2:33 AM UTC
HealthDr. Reddy’s Sets November 2026 Target for Generic Semaglutide ReturnBy Naomi CalderOct 24, 2026, 3:34 PM UTC
BusinessDr. Reddy’s Q2 Profit for the Period Falls 36% to ₹9.13 BillionBy Helena WardOct 24, 2026, 12:58 AM UTC
InvestingThe Economic Times Reports Dr. Reddy’s Dip Below 20-Day EMA in Early TradeBy Celia RowanOct 22, 2026, 12:52 PM UTC
